Management of latent tuberculosis infection in immigrants.
Marks
Suzanne M
SM
Ijaz
Kashef
K
Iademarco
Michael F
MF
D000995:Antitubercular Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics*; D056486:Chemical and Drug Induced Liver Injury; D003362:Cost-Benefit Analysis; D024881:Drug Resistance, Bacterial; D004641:Emigration and Immigration; D017048:Health Care Costs; D006801:Humans; D011718:Pyrazinamide / Q000008:administration & dosage; D012293:Rifampin / Q000008:administration & dosage; D014376:Tuberculosis / Q000175:diagnosis / Q000188:drug therapy*
D000995:Antitubercular Agents; D011718:Pyrazinamide; D012293:Rifampin